1/295
Comprehensive set of 200 vocabulary practice flashcards covering Burns, Shock states, SIRS/MODS, Chronic Neurodegenerative diseases, Stroke, ICP/Head injuries, Spinal Cord Injury, and Immunity/HIV.
Superficial (First-Degree) Burn
A burn involving only the epidermis; appears red or pink, dry, painful or tender, blanches with pressure, lacks blisters, and typically heals in several days without scarring.
TBSA Burn Resuscitation Calculation Exclusion
Superficial (first-degree) burns are not included when calculating total body surface area (TBSA) for major-burn fluid resuscitation.
Superficial Partial-Thickness (Second-Degree) Burn
A burn extending through the epidermis into the superficial dermis; characterized by pink or red, moist, shiny, blistered tissue that is very painful and blanches briskly.
Superficial Partial-Thickness Burn Healing Time
Generally heals in approximately 1–3weeks if uncomplicated, often resulting in little scarring.
Deep Partial-Thickness (Second-Degree) Burn
A burn extending deeper into the dermis; appears mottled red or white or waxy, relatively dry, may have fewer blisters, and shows sluggish or absent blanching.
Deep Partial-Thickness Burn Sensation and Healing
Sensation may be reduced because nerve endings are damaged (though pressure can still cause pain); healing is prolonged, scarring and contractures are more likely, and skin grafting may be required.
Full-Thickness (Third-Degree) Burn
A burn that destroys the entire epidermis and dermis and may extend into subcutaneous tissue; appears white, waxy, brown, black, leathery, or charred, and is dry and nonblanching.
Full-Thickness Burn Sensation and Regeneration
The center is often insensate or painless because nerve endings are destroyed (edges may hurt); it cannot reliably regenerate skin and typically requires surgical excision and skin grafting.
Fourth-Degree Burn
A burn extending through the skin into underlying fat, muscle, tendon, or bone; appears charred, black, or deeply destroyed, carries high infection risk, and may require amputation or reconstruction.
Inhalation Injury: Upper Airway vs. Lower Airway
Heat injury typically affects the upper airway, whereas smoke and toxic chemicals injure lower airways and alveoli, creating swelling that can progress over hours and cause obstruction.
Airway Casts in Smoke Inhalation
Cast-like plugs formed from smoke-induced inflammation, mucosal sloughing, and thick secretions that can obstruct airflow, leading to atelectasis and hypoxemia.
Carbon Monoxide (CO) Pathophysiology
Binds to hemoglobin with a significantly higher affinity than oxygen, displacing oxygen and drastically impairing peripheral oxygen delivery.
Pulse Oximetry in Carbon Monoxide Poisoning
Provides a falsely reassuring, normal-appearing oxygen saturation reading because standard pulse oximeters cannot distinguish carboxyhemoglobin from oxyhemoglobin.
Carbon Monoxide Poisoning Management
Administer 100% high-flow oxygen immediately and obtain arterial blood gas analysis with co-oximetry to determine the carboxyhemoglobin level.
Cyanide Toxicity Mechanism
Inhibits mitochondrial cellular oxygen utilization (mitochondrial toxicity), halting aerobic ATP production and precipitating severe lactic acidosis, altered mental status, seizures, and cardiovascular collapse.
Physical Signs Indicating Inhalation Injury
Burns to the face, neck, or upper chest; singed nasal hairs, eyebrows, or facial hair; soot around the nose or mouth; and carbonaceous (black/sooty) sputum.
Respiratory Manifestations of Inhalation Injury
Hoarseness, voice changes, cough, wheezing, stridor, drooling, difficulty swallowing, dyspnea, and increased work of breathing.
Cherry-Red Skin Appearance in CO Poisoning
A classic manifestation of carbon monoxide toxicity that is actually uncommon in practice; its absence never rules out significant carbon monoxide poisoning.
Priority Airway Action in Suspected Inhalation Injury
Perform early airway evaluation and prepare for prompt endotracheal intubation before progressive airway edema renders intubation impossible.
Initial Thermal Burn Cooling
Cool the burn using cool running tap water; never use ice, and promptly cover the patient with clean, dry materials to prevent hypothermia.
Resuscitation Fluid of Choice in Major Burns
Isotonic crystalloids, most commonly Lactated Ringer's solution, administered through large-bore intravenous lines.
Adult Urine Output Target in Burn Resuscitation
At least 0.5mL/kg/hr, typically corresponding to approximately 30–50mL/hr in an average adult.
Electrical Burn Resuscitation Endpoint
Requires higher hourly urine output targets than standard thermal burns to prevent acute kidney injury from deep-muscle breakdown and myoglobinuria.
Analgesia Administration Route in Acute Major Burns
Intravenous opioids are the preferred standard of care; oral or intramuscular routes are avoided due to erratic absorption from impaired tissue perfusion.
Nutritional Support in Major Burns
Early initiation of high-calorie, high-protein nutrition to counteract severe hypermetabolism, tissue catabolism, and massive nitrogen losses.
Burn Shock Pathophysiology
A combined hypovolemic and distributive shock resulting from widespread capillary leak, massive fluid shifts into interstitial spaces, and severe intravascular volume depletion.
Burn-Induced Acute Kidney Injury
Renal injury triggered by hypoperfusion, hypovolemia, nephrotoxic complications, or tubular obstruction caused by myoglobinuria from deep electrical/muscle trauma.
Early Electrolyte Shifts in Burn Trauma
Early hyperkalemia occurs due to massive cellular destruction and potassium release; hyponatremia and metabolic acidosis often develop concomitantly.
Escharotomy
A surgical incision made through rigid, inelastic, full-thickness burn eschar to relieve internal pressure and restore perfusion or ventilation without removing the eschar.
Indications for Escharotomy
Circumferential extremity or torso burns where internal tissue pressure compromises distal blood flow or severely restricts chest wall excursion and ventilation.
Neurovascular Warning Signs for Extremity Escharotomy
Progressive extremity pain, tightness, paresthesia, delayed capillary refill, pallor, coolness, and weak or disappearing Doppler pulse signals.
Escharotomy vs. Fasciotomy
Escharotomy incises through the burn eschar down to subcutaneous tissue; fasciotomy is a deeper surgical incision that divides muscular fascia to treat true compartment syndrome.
Hypovolemic Shock Pathophysiology
Actual loss of circulating intravascular volume leads to decreased venous return (preload), reduced stroke volume and cardiac output, and inadequate tissue perfusion.
Common Etiologies of Hypovolemic Shock
Hemorrhage, dehydration, severe vomiting, profuse diarrhea, extensive burns, and fluid shifting via third spacing.
Clinical Manifestations of Hypovolemic Shock
Tachycardia, hypotension (often a late sign), weak/thready pulses, cool clammy pale skin, narrowed pulse pressure, thirst, flat neck veins, delayed capillary refill, and oliguria.
Primary Interventions for Hypovolemic Shock
Control volume/blood loss, administer oxygen, establish large-bore IV access, infuse isotonic crystalloids, and transfuse blood products for acute hemorrhage.
Septic Shock Pathophysiology
A dysregulated host response to infection resulting in widespread vasodilation, profound capillary leakage, maldistributed microvascular blood flow, and cellular dysoxia.
Common Anatomic Sources in Sepsis
Lungs (pneumonia), urinary tract (urosepsis), intra-abdominal cavity, skin and soft tissues, and indwelling central lines/catheters.
Early (Warm/Hyperdynamic) Septic Shock
Presents with fever (or hypothermia), tachycardia, tachypnea, warm and flushed skin, and bounding peripheral pulses.
Late (Cold/Hypodynamic) Septic Shock
Characterized by persistent hypotension, cool and mottled extremities, altered mental status, profound oliguria, and progressive multiple organ failure.
MAP Resuscitation Goal in Septic Shock
Achieve and maintain a Mean Arterial Pressure (MAP) of generally ≥65mmHg using IV crystalloids and vasopressors.
First-Line Vasopressor in Septic Shock
Norepinephrine is the first-line vasopressor administered to restore vascular tone and maintain adequate MAP after fluid resuscitation.
Cardiogenic Shock Pathophysiology
Primary myocardial pump failure leading to severely reduced cardiac output and inadequate end-organ perfusion despite adequate or elevated intravascular volume and filling pressures.
Common Etiologies of Cardiogenic Shock
Acute myocardial infarction (classic cause), end-stage heart failure, acute cardiomyopathy, severe dysrhythmias, and acute valvular or mechanical disruptions.
Clinical Findings of Cardiogenic Shock
Hypotension, tachycardia, weak pulses, cool clammy skin, dyspnea, pulmonary crackles/edema, jugular venous distention (JVD), oliguria, and altered mentation.
Fluid Administration Caution in Cardiogenic Shock
Fluid boluses must be administered with extreme caution because excess volume elevates ventricular filling pressures and drastically worsens pulmonary edema.
Neurogenic Shock Pathophysiology
Loss of sympathetic vasomotor tone (usually from cervical or high thoracic spinal cord injury) leading to massive venous pooling, systemic vasodilation, and unopposed vagal tone.
Hemodynamic Hallmarks of Neurogenic Shock
Hypotension accompanied by bradycardia (due to unopposed parasympathetic vagal stimulation) and warm, dry skin.
Interventions for Neurogenic Shock
Spinal stabilization, airway/ventilatory support, cautious IV crystalloid administration, vasopressors to restore vascular tone, and atropine for symptomatic bradycardia.
Anaphylactic Shock Pathophysiology
An IgE-mediated type I hypersensitivity reaction causing massive degranulation of mast cells and basophils, releasing histamine, leukotrienes, and other vasoactive mediators.
Common Triggers of Anaphylactic Shock
Foods (e.g., peanuts, shellfish), medications (e.g., antibiotics), insect venom/stings, and latex.
Clinical Manifestations of Anaphylaxis
Urticaria, pruritus, angioedema, stridor, wheezing, dyspnea, profound hypotension, tachycardia, and gastrointestinal cramping or vomiting.
First-Line Drug for Anaphylactic Shock
Intramuscular (IM) epinephrine administered in the anterolateral mid-outer thigh is the mandatory first-line treatment.
Adjunctive Therapies in Anaphylaxis
Antihistamines, bronchodilators, and corticosteroids; these serve as secondary adjunctive agents and never substitute for immediate epinephrine.
Hypovolemic Shock Differentiation
Differentiated by evidence of acute volume loss, cool/clammy skin, tachycardia, flat neck veins, and an absence of pulmonary congestion.
Cardiogenic Shock Differentiation
Differentiated by evidence of cardiac pump dysfunction, marked pulmonary crackles, jugular venous distention, and high ventricular preload.
Neurogenic Shock Differentiation
Differentiated by the unique coexistence of persistent hypotension with bradycardia and warm, dry skin following a high spinal cord injury.
Prerenal Azotemia in Shock
An elevation in serum BUN and creatinine accompanied by oliguria, resulting directly from severe hypoperfusion and reduced glomerular filtration.
Shock Liver (Ischemic Hepatitis)
Severe hepatic parenchymal hypoxia caused by hypoperfusion, resulting in sharp, marked elevations in serum AST and ALT, hyperbilirubinemia, and prolonged PT/INR.
Serum Lactate in Shock
Elevates as hypoperfused cells switch from aerobic metabolism to anaerobic glycolysis, serving as a reliable surrogate marker of cellular hypoxia and shock severity.
Systemic Inflammatory Response Syndrome (SIRS)
A widespread, dysregulated systemic inflammatory cascade triggered by either infectious insults (sepsis) or sterile tissue trauma (e.g., burns, pancreatitis, major surgery).
SIRS Temperature Criterion
Core body temperature of >38∘C (100.4∘F) or <36∘C (96.8∘F).
SIRS Heart Rate Criterion
Heart rate greater than 90beats/min.
SIRS Respiratory Criterion
Respiratory rate greater than 20breaths/min or an arterial carbon dioxide tension (PaCO2) of <32mmHg.
SIRS White Blood Cell Count Criterion
White blood cell count of >12,000/μL, <4,000/μL, or greater than 10% immature band forms.
Multiple Organ Dysfunction Syndrome (MODS)
The progressive, altered dysfunction of two or more organ systems such that physiological homeostasis cannot be maintained without active therapeutic intervention.
Classic Shock Laboratory Pattern
A rising serum lactate, falling hourly urine output, and rising serum creatinine, indicating worsening global tissue hypoperfusion.
Normal Blood Pressure in Early Shock
Compensatory mechanisms (tachycardia, vasoconstriction) can maintain a normal blood pressure early; therefore, normal blood pressure never excludes early shock.
Multiple Sclerosis (MS) Pathophysiology
An autoimmune inflammatory disorder of the CNS wherein autoreactive T cells attack myelin sheaths and oligodendrocytes, creating demyelinating plaques and impaired axonal conduction.
Uhthoff Phenomenon
The temporary, transient worsening of pre-existing neurological deficits in patients with multiple sclerosis triggered by elevated body temperature, heat, fever, or physical exertion.
Parkinson Disease Pathophysiology
Progressive neurodegeneration of pigmented dopaminergic neurons in the substantia nigra pars compacta, depleting dopamine levels within the striatum.
Lewy Bodies
Abnormal intracellular eosinophilic protein aggregates containing alpha-synuclein that deposit within neurons in Parkinson disease.
Neurotransmitter Imbalance in Parkinson Disease
A primary deficit of inhibitory dopamine creates a relative excess of excitatory acetylcholine activity within the basal ganglia circuitry.
Amyotrophic Lateral Sclerosis (ALS) Pathophysiology
A fatal neurodegenerative disease characterized by progressive loss of both upper motor neurons (brain/spinal cord) and lower motor neurons (brainstem/anterior horns).
Preserved Functions in ALS
Sensory perception, cognitive processing (in most), and bowel and bladder sphincter control remain largely intact throughout early disease stages.
Primary Cause of Death in ALS
Progressive respiratory muscle weakness leading to ventilatory failure, weak cough, aspiration, and fatal pneumonia.
Guillain-Barré Syndrome (GBS) Pathophysiology
An acute, post-infectious, immune-mediated peripheral neuropathy where antibodies and cellular infiltrates attack Schwann cells, peripheral nerve myelin, or axons.
Common Antecedent Infection in GBS
Gastroenteritis caused by Campylobacter jejuni, which triggers cross-reactive anti-ganglioside antibodies through molecular mimicry.
Hallmark Presentation of GBS
Acute, rapidly progressive, symmetrical ascending motor weakness beginning in the lower extremities, accompanied by hyporeflexia or areflexia.
Myasthenia Gravis (MG) Pathophysiology
An autoimmune disorder where autoantibodies attack postsynaptic nicotinic acetylcholine receptors (AChRs) at the neuromuscular junction, blocking neuromuscular transmission.
Hallmark Presentation of Myasthenia Gravis
Fluctuating, fatigable skeletal muscle weakness that worsens with repetitive activity and improves significantly following periods of rest.
Clinical Manifestations of Multiple Sclerosis
Optic neuritis (painful unilateral visual loss), diplopia, nystagmus, fatigue, paresthesias, spasticity, limb weakness, gait ataxia, and neurogenic bladder.
TRAP Acronym (Parkinson Disease)
Tremor (resting, 'pill-rolling'), Rigidity ('cogwheel'), Akinesia or bradykinesia (slowness of movement), and Postural instability.
Additional Features of Parkinson Disease
Masked facies, hypophonia (soft voice), micrographia (small handwriting), festinating/shuffling gait, decreased arm swing, drooling, and constipation.
Combined Motor Signs in ALS
Concurrent upper motor neuron signs (spasticity, hyperreflexia, Babinski sign) and lower motor neuron signs (muscle wasting, flaccidity, fasciculations).
Bulbar Symptoms in ALS
Dysarthria (difficulty speaking), dysphagia (difficulty swallowing), weak cough, tongue atrophy, and drooling caused by lower cranial nerve motor neuron degeneration.
Emergent Complications to Monitor in GBS
Ascending paralysis reaching the diaphragm (falling forced vital capacity requiring mechanical ventilation) and autonomic instability (severe swings in heart rate and blood pressure).
Myasthenic Crisis
An acute, life-threatening exacerbation of myasthenia gravis characterized by severe respiratory muscle weakness causing ventilatory failure, often triggered by infection or stress.
Cholinergic Crisis
Severe flaccid weakness caused by excessive acetylcholinesterase inhibitor dosing, accompanied by muscarinic overstimulation signs: salivation, lacrimation, urination, diarrhea, GI cramps, emesis, and bradycardia.
Identification of an Acute MS Relapse
New or worsening neurological symptoms lasting at least 24hours in the absence of fever, infection, or metabolic disruption, separated by ≥30days from a prior attack.
MS Pseudoexacerbation
A temporary worsening of baseline chronic MS symptoms driven by fever, systemic infection (e.g., UTI), heat, or physical fatigue, without new demyelinating plaque formation.
Edrophonium (Tensilon) Test
A historical diagnostic test utilizing edrophonium, an ultra-short-acting acetylcholinesterase inhibitor that rapidly boosts acetylcholine, producing brief improvement in myasthenic ptosis or weakness.
Antidote Required During Tensilon Testing
Atropine sulfate must be immediately available at the bedside to reverse severe edrophonium-induced bradycardia, excessive secretions, and bronchospasm.
Modern Diagnostic Tests for Myasthenia Gravis
Serum anti-acetylcholine receptor (AChR) antibodies, anti-MuSK antibodies, repetitive nerve stimulation studies, and single-fiber electromyography (SFEMG).
Pathological Comparison: MS vs. GBS
MS targets the central nervous system myelin sheaths and oligodendrocytes; GBS targets peripheral nerve myelin and Schwann cells.
Pathological Comparison: MG vs. ALS
MG is a disorder of the neuromuscular junction with intact nerves and sensory pathways; ALS is a degenerative disease of upper and lower motor neurons.
Right Hemispheric Stroke Sensorimotor Deficits
Contralateral left-sided hemiparesis or hemiplegia and left-sided sensory loss.
Right Hemispheric Stroke Neurobehavioral Features
Left-sided spatial neglect, impaired visuospatial perception, impulsivity, poor safety judgment, lack of insight (anosognosia), and emotional lability.
Left Hemispheric Stroke Sensorimotor Deficits
Contralateral right-sided hemiparesis or hemiplegia and right-sided sensory loss.
Left Hemispheric Stroke Cognitive Features
Aphasia (expressive, receptive, or global in dominant hemisphere), alexia, agraphia, acalculia, and a slow, cautious, hesitant behavioral style.